Dendroaspis natriuretic peptide binds to the natriuretic peptide clearance receptor

被引:37
作者
Johns, Douglas G. [1 ]
Ao, Zhaohui
Heidrich, Bradley J.
Hunsberger, Gerald E.
Graham, Taylor
Payne, Lisa
Elshourbagy, Nabil
Lu, Quinn
Aiyar, Nambi
Douglas, Stephen A.
机构
[1] GlaxoSmithKline, Vasc Biol & Thrombosis Dept, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
[2] GlaxoSmithKline, Resp & Inflammatory Dis Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
[3] GlaxoSmithKline, Gene Express & Prot Biochem, King Of Prussia, PA 19406 USA
关键词
natriuretic peptides; natriuretic peptide clearance receptor; NPR-C; heart failure; DNP; Dendroaspis natriuretic peptide;
D O I
10.1016/j.bbrc.2007.04.079
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dendroaspis natriuretic peptide (DNP) is a newly-described natriuretic peptide which lowers blood pressure via vasodilation. The natriuretic peptide clearance receptor (NPR-C) removes natriuretic peptides from the circulation, but whether DNP interacts with human NPR-C directly is unknown. The purpose of this study was to test the hypothesis that DNP binds to NPR-C. ANP, BNP, CNP, and the NPR-C ligands AP-811 and cANP(4-23) displaced [I-125]-ANP from NPR-C with pM-to-nM K-i values. DNP displaced [I-125]-ANP from NPR-C with nM potency, which represents the first direct demonstration of binding of DNP to human NPR-C. DNP showed high pM affinity for the GGA receptor and no affinity for GC-B (K-i > 1000 nM). DNP was nearly 10-fold more potent than ANP at stimulating cGMP production in GGA expressing cells. Blockade of NPR-C might represent a novel therapeutic approach in augmenting the known beneficial actions of DNP in cardiovascular diseases such as hypertension and heart failure. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:145 / 149
页数:5
相关论文
共 18 条
[1]   Dendroaspis natriuretic peptide relaxes isolated human arteries and veins [J].
Best, PJM ;
Burnett, JC ;
Wilson, SH ;
Holmes, DR ;
Lerman, A .
CARDIOVASCULAR RESEARCH, 2002, 55 (02) :375-384
[2]  
Burnett John C Jr, 2006, J Cardiol, V48, P235
[3]   Natriuretic peptide receptors and neutral endopeptidase in mediating the renal actions of a new therapeutic synthetic natriuretic peptide Dendroaspis natriuretic peptide [J].
Chen, HH ;
Lainchbury, JG ;
Burnett, JC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (06) :1186-1191
[4]  
CHO Y, 1999, HEART DIS, V5, P305
[5]   Mechanism of relaxations to dendroaspis natriuretic peptide in canine coronary arteries [J].
Collins, E ;
Bracamonte, MP ;
Burnett, JC ;
Miller, VM .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 (04) :614-618
[6]  
Fábrega E, 2001, AM J GASTROENTEROL, V96, P2724
[7]  
Fornwald James A., 2007, V388, P95
[8]   MOLECULAR-BIOLOGY OF THE NATRIURETIC PEPTIDES AND THEIR RECEPTORS [J].
KOLLER, KJ ;
GOEDDEL, DV .
CIRCULATION, 1992, 86 (04) :1081-1088
[9]  
KOYAMA S, 1994, INT J PEPT PROT RES, V43, P332
[10]   Relationship of plasma Dendroaspis natriuretic peptide-like immunoreactivity and echocardiographic parameters in chronic haemodialysis patients [J].
Lee, S ;
Park, SK ;
Kang, KP ;
Kang, SK ;
Kim, SZ ;
Kim, W .
NEPHROLOGY, 2004, 9 (03) :171-175